CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas
Tobacco Stocks in Focus as Cigarette Prices Rise in New York
by Zacks Equity Research
The news of cigarette price hike in New York City and other legislations to reduce the number of smokers have raised concerns of accelerated sales declines for traditional cigarettes.
What You Should Know About Fred's Apart From Dismal Comps
by Zacks Equity Research
Fred's (FRED) is yet to recover from the cancelled Walgreens-Rite Aid merger. The company has also been struggling with declining sales owing to lower comps and store closures.
Investors Are Keeping An Eye On Q2 Earnings
by Zacks Equity Research
Investors Are Keeping An Eye On Q2 Earnings
Q2 Earnings Rundown: KORS, RL, CVS & More
by Mark Vickery
The S&P 500 and Dow both hit new record highs yesterday, but are down marginally in today's pre-market.
CVS Health Beats on Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health(CVS) rides high on Pharmacy Services segment in Q2.
Rite Aid Seems the Forbidden Fruit, Stock Down 20% in July
by Zacks Equity Research
Ever since Rite Aid Corp.'s (RAD) merger deal with Walgreens Boots Alliance Inc. (WBA) fell through on Jun 29, the stock has turned in to a forbidden fruit for investors.
Fred's Posts Dismal Comparable June Store Sales, Stock Down
by Zacks Equity Research
Fred's, (FRED), which has been struggling to recover from the blow of a failed merger between Rite Aid Corporation (RAD) and Walgreens Boots Alliance (WBA), recently announced soft June comparable store sales.
Fred's Stock Falls, Walgreens & Rite Aid Merger Deal Revised
by Zacks Equity Research
Fred's, Inc. (FRED) or Fred's Pharmacy lost over 20% yesterday after Walgreens Boots Alliance, Inc. (WBA) decided not to proceed with its planned takeover of the rival drugstore Rite Aid Corporation (RAD) due to various antitrust issues, as per Bloomberg. The cancelled merger significantly hurt Rite Aid???s stock too, which fell 26.46% yesterday.
Have You Noticed Potential in Herbalife? Stock Adds 48% YTD
by Zacks Equity Research
Shares of Herbalife (HLF) have exhibited a bullish run on the index.
What Will Rite Aid-Walgreens Merger Mean to Fred's (FRED)?
by Zacks Equity Research
Shares of Fred's (FRED) rallied nearly 23% on Jun 26 on rumors about the FTC approval of the acquisition of Rite Aid by Walgreens.
CVS Health (CVS) Down 3.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Could Amazon Be the Next Big Pharmacy Giant?
by Madeleine Johnson
Amazon is reportedly looking to expand into new territory. According to CNBC, the e-commerce giant is trying to figure out how it can break into the multi-billion-dollar pharmacy industry.
The Zacks Analyst Blog Highlights: MasterCard, CVS Health, Colgate-Palmolive, Charter Communications and Norfolk Southern
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MasterCard, CVS Health, Colgate-Palmolive, Charter Communications and Norfolk Southern
Top Research Reports for Today: MA, CVS, CL & More
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including MasterCard (MA), CVS Health (CVS) and Colgate-Palmolive (CL).
CVS Health Beats on Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Currently, CVS Health has a Zacks Rank #3 (Hold) but that could change following its first quarter 2017 earnings report which has just released.
Rite Aid (RAD) Stock Up on Better-than-Expected Q4 Results
by Zacks Equity Research
Rite Aid (RAD) posted fourth-quarter fiscal 2017 results.
CVS Health Launches Reduced Rx for Affordable Medication
by Zacks Equity Research
CVS Health Corporation (CVS), a leading name in pharmacy benefit and retail pharmacy, recently announced the launch of a prescription savings program-Reduced Rx.
CVS Health (CVS) Up 4% Since Earnings Report: Can It Continue?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health Adopts Epic EHR for Specialty Care Programs
by Zacks Equity Research
CVS Health Corporation (CVS) recently announced that it has chosen Epic as the electronic health record (EHR) system for CVS Specialty's care management programs.
CVS Health (CVS) Beats on Q4 Earnings, Retains '17 View
by Zacks Equity Research
CVS Health Corporation (CVS) reported fourth-quarter 2016 adjusted earnings per share (EPS) of $1.71, up 11.8% year over year.
CVS Health Tops Q4 Earnings, Misses on Revenues
by Zacks Equity Research
CVS Health posted mixed fourth quarter results with earnings beating the Zacks Consensus Estimate while sales missed the mark.
Paycom Software (PAYC) Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Paycom Software, Inc. (PAYC) is set to report fourth-quarter 2016 results on Feb 8.
Broadridge Financial (BR) Q2 Earnings: What's in Store?
by Zacks Equity Research
Broadridge Financial Solutions Inc. (BR) is set to report fiscal second-quarter 2017 results on Feb 8.
CDW Corp. (CDW) Q4 Earnings: What's in the Cards this Time?
by Zacks Equity Research
CDW Corp. (CDW) is set to report fourth-quarter 2016 results on Feb 7.